GlassScriptPhysician profile
Danielle Jessica Scribani
NPI 1699251025
$4,360.35
in general payments reported to CMS, 2019-2025
10 companies · $556 in 2025
The $556 reported for 2025 was more than what 82% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $583 · 2022: $1,018 · 2023: $78.78 · 2024: $2,124 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,690 · Travel and Lodging: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,690.02 |
| Travel and Lodging | $1,068.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,441.32 | 2024 | |
| Tactile Systems Technology INC | $760.22 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Penumbra, INC. | $616.92 | 2022-2024 | Indigo System |
| Medtronic, INC. | $488.44 | 2021-2025 | Valiant Captivia, Endurant Iis |
| Bard Peripheral Vascular, INC. | $442.24 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $291.43 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Silk Road Medical, INC. | $162.97 | 2021 | |
| Integra Lifesciences Corporation | $78.03 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Astrazeneca Pharmaceuticals LP | $42.33 | 2023 | Tagrisso |
| Shockwave Medical, INC | $36.45 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Scribani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.